Anuradha Chakravarthy
Faculty Member
Last active: 3/27/2014

  1. Survival Benefit of Adjuvant Radiation Therapy for Gastric Cancer following Gastrectomy and Extended Lymphadenectomy. Snyder RA, Castaldo ET, Bailey CE, Phillips SE, Chakravarthy AB, Merchant NB (2012) Int J Surg Oncol : 307670
    › Primary publication · 22778937 (PubMed) · PMC3388431 (PubMed Central)
  2. Statistical comparison of dynamic contrast-enhanced MRI pharmacokinetic models in human breast cancer. Li X, Welch EB, Chakravarthy AB, Xu L, Arlinghaus LR, Farley J, Mayer IA, Kelley MC, Meszoely IM, Means-Powell J, Abramson VG, Grau AM, Gore JC, Yankeelov TE (2012) Magn Reson Med 68(1): 261-71
    › Primary publication · 22127821 (PubMed) · PMC3291742 (PubMed Central)
  3. Phase II Trial of Paclitaxel/Cisplatin Followed by Surgery and Adjuvant Radiation Therapy and 5-Fluorouracil/Leucovorin for Gastric Cancer (ECOG E7296). Chakravarthy AB, Catalano PJ, Mondschein JK, Rosenthal DI, Haller DG, Whittington R, Spitz FR, Wagner H, Sigurdson ER, Tschetter LK, Bayer GK, Mulcahy MF, Benson AB (2012) Gastrointest Cancer Res 5(6): 191-7
    › Primary publication · 23293700 (PubMed) · PMC3533847 (PubMed Central)
  4. Lymph node ratio and preoperative CA 19-9 levels predict overall survival and recurrence-free survival in patients with resected pancreatic adenocarcinoma. Wentz SC, Zhao ZG, Shyr Y, Shi CJ, Merchant NB, Washington K, Xia F, Chakravarthy AB (2012) World J Gastrointest Oncol 4(10): 207-15
    › Primary publication · 23444312 (PubMed) · PMC3581835 (PubMed Central)
  5. Controversies in radiation for upper rectal cancers. Chan E, Wise PE, Chakravarthy AB (2012) J Natl Compr Canc Netw 10(12): 1567-72
    › Primary publication · 23221791 (PubMed)
  6. A phase I study of cetuximab in combination with gemcitabine and radiation for locally advanced pancreatic cancer. Chakravarthy AB, Tsai CJ, O'Brien N, Lockhart AC, Chan E, Parikh A, Berlin JD, Merchant N (2012) Gastrointest Cancer Res 5(4): 112-8
    › Primary publication · 23077684 (PubMed) · PMC3433259 (PubMed Central)
  7. An algorithm for longitudinal registration of PET/CT images acquired during neoadjuvant chemotherapy in breast cancer: preliminary results. Li X, Abramson RG, Arlinghaus LR, Chakravarthy AB, Abramson V, Mayer I, Farley J, Delbeke D, Yankeelov TE (2012) EJNMMI Res 2(1): 62
    › Primary publication · 23157877 (PubMed) · PMC3520720 (PubMed Central)
  8. Motion correction in diffusion-weighted MRI of the breast at 3T. Arlinghaus LR, Welch EB, Chakravarthy AB, Xu L, Farley JS, Abramson VG, Grau AM, Kelley MC, Mayer IA, Means-Powell JA, Meszoely IM, Gore JC, Yankeelov TE (2011) J Magn Reson Imaging 33(5): 1063-70
    › Primary publication · 21509862 (PubMed) · PMC3081111 (PubMed Central)
  9. Integration of diffusion-weighted MRI data and a simple mathematical model to predict breast tumor cellularity during neoadjuvant chemotherapy. Atuegwu NC, Arlinghaus LR, Li X, Welch EB, Chakravarthy BA, Gore JC, Yankeelov TE (2011) Magn Reson Med 66(6): 1689-96
    › Primary publication · 21956404 (PubMed) · PMC3218213 (PubMed Central)
  10. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA (2011) J Clin Invest 121(7): 2750-67
    › Primary publication · 21633166 (PubMed) · PMC3127435 (PubMed Central)